Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2018;68:394.
PubMed
Google Scholar
Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. The Lancet. 2016;388:73–85.
Article
CAS
Google Scholar
Chen B-B, Tien Y-W, Chang M-C, Cheng M-F, Chang Y-T, Yang S-H, Wu C-H, Kuo T-C, Shih IL, Yen R-F, Shih T. Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer. Eur J Nucl Med Mol Imaging. 2018;45:1205–17.
Article
CAS
Google Scholar
Garrido-Laguna I, Hidalgo M. Pancreatic cancer: from state-of-the-art treatments to promising novel therapies. Nat Rev Clin Oncol. 2015;12:319.
Article
CAS
Google Scholar
Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245.
Article
CAS
Google Scholar
Desch AN, Randolph GJ, Murphy K, Gautier EL, Kedl RM, Lahoud MH, Caminschi I, Shortman K, Henson PM, Jakubzick CV. CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell–associated antigen. J Exp Med. 2011;208:1789–97.
Article
CAS
Google Scholar
Shikhar M, Carolyn DB, Steve C, Elizabeth G-M, Colleen AC, Mingli L, Gina S, Mohamed LS, Michelle HN, Melanie BT, et al. Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer. J Hematol Oncol. 2017;10:1–13.
Article
Google Scholar
Franchi G, Manzoni MF. Cytological Ki-67 in pancreatic endocrine tumors: a new “must”? Gland Surg. 2014;3:219.
PubMed
PubMed Central
Google Scholar
Jain R, Fischer S, Serra S, Chetty R. The use of cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver. Appl Immunohistochem Mol Morphol. 2010;18:9.
Article
CAS
Google Scholar
Jalava P, Kuopio T, Juntti-Patinen L, Kotkansalo T, Kronqvist P, Collan Y. Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index. Histopathology. 2006;48:674–82.
Article
CAS
Google Scholar
Zapata M, Cohen C, Siddiqui MT. Immunohistochemical expression of SMAD4, CK19, and CA19-9 in fine needle aspiration samples of pancreatic adenocarcinoma: utility and potential role. CytoJournal. 2007;4:13.
Article
Google Scholar
Tamm EP, Silverman PM, Charnsangavej C, Evans DB. Diagnosis, staging, and surveillance of pancreatic cancer. AJR Am J Roentgenol. 2003;180:1311.
Article
Google Scholar
Akisik MF, Sandrasegaran K, Bu G, Lin C, Hutchins GD, Chiorean EG. Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy. Radiology. 2010;256:441.
Article
Google Scholar
Gerwing M, Herrmann K, Helfen A, Schliemann C, Berdel W, Eisenblätter M, Wildgruber M. The beginning of the end for conventional RECIST—novel therapies require novel imaging approaches. Nat Rev Clin Oncol. 2019;16:442–58.
Article
CAS
Google Scholar
Larue RTHM, Defraene G, De Ruysscher D, Lambin P, van Elmpt W. Quantitative radiomics studies for tissue characterization: a review of technology and methodological procedures. Br J Radiol. 2017;90:20160665.
Article
Google Scholar
Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278:563.
Article
Google Scholar
Aerts HJWL. The potential of radiomic-based phenotyping in precision medicine: a review. JAMA Oncol. 2016;2:1636–42.
Article
Google Scholar
Pak L, Gonen M, Seier K, Balachandran V, D’Angelica M, Jarnagin W, Kingham T, Allen P, Do R, Simpson A. Can physician gestalt predict survival in patients with resectable pancreatic adenocarcinoma? Abdom Radiol. 2018;43:2113–8.
Article
Google Scholar
Eilaghi A, Baig S, Zhang Y, Zhang J, Karanicolas P, Gallinger S, Khalvati F, Haider MA. CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma—a quantitative analysis. BMC Med Imaging. 2017;17:38–38.
Article
Google Scholar
Attiyeh M, Chakraborty J, Doussot A, Langdon-Embry L, Mainarich S, Gönen M, Balachandran V, D’Angelica M, DeMatteo R, Jarnagin W, et al. Survival prediction in pancreatic ductal adenocarcinoma by quantitative computed tomography image analysis. Ann Surg Oncol. 2018;25:1034–42.
Article
Google Scholar
Haider MA, Vosough A, Khalvati F, Kiss A, Ganeshan B, Bjarnason GA. CT texture analysis: a potential tool for prediction of survival in patients with metastatic clear cell carcinoma treated with sunitinib. Cancer Imaging. 2017;17:4.
Article
Google Scholar
Institute for Laboratory Animal Research Institute for Laboratory Animal Research. Guide for the care and use of laboratory animals. 8th ed. Washington: National Academies Press; 2011.
Google Scholar
Bai Z, Shi Y, Wang J, Qiu L, Teng G, Zhang F, Yang X. Multi-modality imaging-monitored creation of rat orthotopic pancreatic head cancer with obstructive jaundice. Oncotarget. 2017;8:54277–84.
PubMed
PubMed Central
Google Scholar
Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, Hruban RH, Rustgi AK, Chang S, Tuveson DA. Trp53 R172H and Kras G12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell. 2005;7:469–83.
Article
CAS
Google Scholar
Stokes WS. Humane endpoints for laboratory animals used in regulatory testing. ILAR J. 2002;43:S31–8.
CAS
PubMed
Google Scholar
Caroline AS, Wayne SR, Kevin WE. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671.
Article
Google Scholar
Eresen A, Hafsa NE, Alic L, Birch SM, Griffin JF, Kornegay JN, Ji JX. Muscle percentage index as a marker of disease severity in golden retriever muscular dystrophy. Muscle Nerve. 2019;60:621–8.
Article
Google Scholar
Li Y, Eresen A, Lu Y, Yang J, Shangguan J, Velichko Y, Yaghmai V, Zhang Z. Radiomics signature for the preoperative assessment of stage in advanced colon cancer. Am J Cancer Res. 2019;9:1429.
PubMed
PubMed Central
Google Scholar
Kim B, Kim J, Ahn S, Joo I, Choi S-Y, Park S, Han J. CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture analysis. Eur Radiol. 2019;29:362–72.
Article
Google Scholar
Choi M, Lee Y, Yoon S, Choi J-I, Jung S, Rha S. MRI of pancreatic ductal adenocarcinoma: texture analysis of T2-weighted images for predicting long-term outcome. Abdom Radiol. 2019;44:122–30.
Article
Google Scholar
Woodruff H, Blé FX, Jochens A, Leijenaar RTH, Ibrahim A, Brindle KM, Heinzmann K, McIntyre DJO, Lambin P. EP-2102: correlating MRI radiomics with biology during therapy in cancer models: a tool for drug development? Radiother Oncol. 2018;127:S1155–6.
Article
Google Scholar
Yue Y, Osipov A, Fraass B, Sandler H, Zhang X, Nissen N, Hendifar A, Tuli R. Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients. J Gastrointest Oncol. 2017;8:127.
Article
Google Scholar